2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission
- PMID: 32265315
- PMCID: PMC7141890
- DOI: 10.1128/mSystems.00245-20
2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission
Erratum in
-
Correction for Dietz et al., "2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission".mSystems. 2020 May 5;5(3):e00375-20. doi: 10.1128/mSystems.00375-20. mSystems. 2020. PMID: 32371473 Free PMC article. No abstract available.
Abstract
With the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in coronavirus disease 2019 (COVID-19), corporate entities, federal, state, county, and city governments, universities, school districts, places of worship, prisons, health care facilities, assisted living organizations, daycares, homeowners, and other building owners and occupants have an opportunity to reduce the potential for transmission through built environment (BE)-mediated pathways. Over the last decade, substantial research into the presence, abundance, diversity, function, and transmission of microbes in the BE has taken place and revealed common pathogen exchange pathways and mechanisms. In this paper, we synthesize this microbiology of the BE research and the known information about SARS-CoV-2 to provide actionable and achievable guidance to BE decision makers, building operators, and all indoor occupants attempting to minimize infectious disease transmission through environmentally mediated pathways. We believe this information is useful to corporate and public administrators and individuals responsible for building operations and environmental services in their decision-making process about the degree and duration of social-distancing measures during viral epidemics and pandemics.
Keywords: COVID-19; SARS-CoV-2; building operations; built environment; novel coronavirus.
Copyright © 2020 Dietz et al.
Figures
References
-
- de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RAM, Galiano M, Gorbalenya AE, Memish ZA, Perlman S, Poon LLM, Snijder EJ, Stephens GM, Woo PCY, Zaki AM, Zambon M, Ziebuhr J. 2013. Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 87:7790–7792. doi:10.1128/JVI.01244-13. - DOI - PMC - PubMed
-
- Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Nicholls J, Yee WKS, Yan WW, Cheung MT, Cheng VCC, Chan KH, Tsang DNC, Yung RWH, Ng TK, Yuen KY, SARS Study Group. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319–1325. doi:10.1016/S0140-6736(03)13077-2. - DOI - PMC - PubMed
-
- World Health Organization. 5 January 2020. Pneumonia of unknown cause – China. World Health Organization, Geneva, Switzerland.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
